The pharmacoepidemiology stack.
Three integrated products powering pharmacoepidemiology workflows for high-validity evidence generation.
Care delivery data in. High-validity evidence out.
One substrate, resolving as it descends: the Curation Platform organizes routinely collected patient data, Pragmatic Registries hold the curated data sets study-ready, and the Evidence Platform enables epidemiologists generate high-validity evidence.
Verantos Curation Platform
An agentic platform that pairs clinical annotators with AI agents to label data, train extraction and inference models, and produce curated data sets from medical records.
- 1 · Data labeling: reference standard data, annotators and AI agents in concert
- 2 · Model training: extraction, imputation, and clinical inference models
- 3 · Curated data sets: validated models applied to records at scale
Verantos Pragmatic Registry
Disease-specific Pragmatic Registries that capture the clinical richness at scale but without the structural constraints of consented registries.
- Cardiovascular · Respiratory · Neuroscience · Metabolic · Gastrointestinal
- Clinically rich data, linked with claims and mortality
Verantos Evidence Platform
A pharmacoepidemiological study design and execution platform that takes epidemiologists from study question to results at a fraction of the time and cost.
- Research Assistant: a conversational AI orchestrating agents across pharmacoepidemiological workflows
- Knowledge and variable design · cohorts, analyses, results
Each product stands alone. The stack compounds.
Each product is available standalone: a Pragmatic Registry subscription, a curation engagement, or the Evidence Platform on its own. Teams enter the stack wherever their program needs it.
Run together, each layer strengthens the next: validated models from the Curation Platform power the Pragmatic Registries, and Pragmatic Registries plug directly into the Evidence Platform. Move seamlessly from high-quality data to high-validity evidence.
One rigorous foundation carries the full evidence portfolio — clinical development, comparative effectiveness, regulatory submissions, label expansion, safety, and post-marketing commitments — each drawing on the same measured, traceable data.
Ready to advance your evidence program?
Speak with our team about how the Verantos pharmacoepidemiology stack can accelerate your timeline.